DYN
Dyne Therapeutics, Inc. Common Stock
stockNASDAQ
dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 15.77 | 2026-10-22 | +8.31% | 3.601 |
| 1M | 16.21 | 2026-09-29 | +5.37% | 2.488 |
| 3M | 25.10 | 2026-07-29 | -31.95% | 1.986 |
| 6M | 17.41 | 2026-04-29 | -1.90% | 1.632 |
| 1Y | 23.63 | 2025-10-29 | -27.72% | 1.843 |
| 2Y | 30.22 | 2024-10-29 | -43.48% | — |
| 5Y | 14.51 | 2021-10-29 | +17.71% | 1.581 |
Dyne Therapeutics, Inc. Common Stock (NASDAQ:DYN) stock price today is $17.08, and today's volume is 1,111,026. DYN is up 0.589% today. The 30 day average volume is 3.04M. DYN market cap is $3.19B with 186.75M shares outstanding.